Gestión de la Calidad

46

Figure 6. Selection of compounds predicted to be active by both AST and Composite endpoint models. Chemical descriptors frequently used in the models were mapped back onto the compound structures.

CH₃ O H OH O OH NH₂ Methyldopa

Descriptor nArOH: Number of aromatic hydroxyls Descriptor nRCOOH: Number of carboxylic acids (aliphatic) CH3 O O CH3 O C H3 N N N H₂ N H₂ Trimethoprim

Descriptor nPyrimidines: Number of pyrimidines Descriptor nArNH2: Number of aromatic amines

REFERENCES

1. Abboud, G., and Kaplowitz, N. (2007). Drug-induced liver injury. Drug Saf 30(4), 277-294.

2. Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., and Monks, T. J. (2000). Role of quinones in toxicology. Chem Res Toxicol 13(3), 135-160.

3. Devillers, J. (1996). Strenghts and weaknesses of the back propagation neural network in QSAR and QSPR studies. In Genetic algorithms in molecular modeling (J.Devillers, Ed.), pp. 1-24. Academic Press, New York, NY.

4. Dybing, E., Nelson, S. D., Mitchell, J. R., Sasame, H. A., and Gillette, J. R. (1976). Oxidation of alpha-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of methyldopa hepatitis. Mol Pharmacol 12(6), 911-920.

5. Ekins, S., Crumb, W. J., Sarazan, R. D., Wikel, J. H., and Wrighton, S. A. (2002). Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel. J. Pharmacol. Exp. Ther. 301(2), 427-434.

6. Fontanarosa, P. B., Rennie, D., and DeAngelis, C. D. (2004). Postmarketing surveillance--lack of vigilance, lack of trust. J. Am. Med. Assoc. 292(21), 2647- 2650.

7. Gisbert, J. P., Gonzalez-Lama, Y., and Mate, J. (2007). Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review. Am J

Gastroenterol. 102(7), 1518-1527.

8. Golbraikh, A., Shen, M., Xiao, Z., Xiao, Y. D., Lee, K. H., and Tropsha, A. (2003). Rational selection of training and test sets for the development of validated QSAR models. J. Comput. Aided Mol. Des 17(2-4), 241-253.

9. Golbraikh, A., and Tropsha, A. (2002). Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. J.

Comput. Aided Mol. Des 16(5-6), 357-369.

10. Guyton, K. Z., Thompson, J. A., and Kensler, T. W. (1993). Role of quinone

methide in the in vitro toxicity of the skin tumor promoter butylated hydroxytoluene hydroperoxide. Chem Res Toxicol 6(5), 731-738.

11. Hall LH., Mohney B, and Kier LB (1991). The Electrotopological State: An Atom Index for QSAR. Quantitative Structure-Activity Relationships 10, 43-51.

12. Hauben, M., and Bate, A. (2009). Decision support methods for the detection of adverse events in post-marketing data. Drug Discov. Today 14(7-8), 343-357.

48

13. Jaeschke, H., Gores, G. J., Cederbaum, A. I., Hinson, J. A., Pessayre, D., and

Lemasters, J. J. (2002). Mechanisms of hepatotoxicity. Toxicol. Sci. 65(2), 166-176. 14. Jensen, B. F., Vind, C., Padkjaer, S. B., Brockhoff, P. B., and Refsgaard, H. H.

(2007). In silico prediction of cytochrome P450 2D6 and 3A4 inhibition using Gaussian kernel weighted k-nearest neighbor and extended connectivity fingerprints, including structural fragment analysis of inhibitors versus noninhibitors. J Med Chem 50(3), 501-511.

15. Johnson, D. E., and Rodgers, A. D. (2006). Computational toxicology: heading toward more relevance in drug discovery and development. Curr. Opin. Drug

Discov. Devel. 9(1), 29-37.

16. Kier LB (1987). Inclusion of Symmetry As A Shape Attribute in Kappa-Index Analysis. Quantitative Structure-Activity Relationships 6, 8-12.

17. Kier LB, and Hall LH. (1991). A Differential Molecular Connectivity Index.

Quantitative Structure-Activity Relationships 10, 134-140.

18. Kier, L. B. (1987). Indexes of molecular shape from chemical graphs. Med. Res.

Rev. 7(4), 417-440.

19. Korhonen, L. E., Turpeinen, M., Rahnasto, M., Wittekindt, C., Poso, A., Pelkonen, O., Raunio, H., and Juvonen, R. O. (2007). New potent and selective cytochrome P450 2B6 (CYP2B6) inhibitors based on three-dimensional quantitative structure- activity relationship (3D-QSAR) analysis. Br. J Pharmacol 150(7), 932-942. 20. Lasser, K. E., Allen, P. D., Woolhandler, S. J., Himmelstein, D. U., Wolfe, S. M.,

and Bor, D. H. (2002). Timing of new black box warnings and withdrawals for prescription medications. J. Am. Med. Assoc. 287(17), 2215-2220.

21. Lavergne, S. N., Park, B. K., and Naisbitt, D. J. (2008). The roles of drug metabolism in the pathogenesis of T-cell-mediated drug hypersensitivity. Curr.

Opin. Allergy Clin Immunol. 8(4), 299-307.

22. Lessigiarska, I., Worth, A. P., Netzeva, T. I., Dearden, J. C., and Cronin, M. T. (2006). Quantitative structure-activity-activity and quantitative structure-activity investigations of human and rodent toxicity. Chemosphere 65(10), 1878-1887. 23. Lewis, D. F., Lake, B. G., Ito, Y., and Anzenbacher, P. (2006). Quantitative

structure-activity relationships (QSARs) within cytochromes P450 2B (CYP2B) subfamily enzymes: the importance of lipophilicity for binding and metabolism.

Drug Metabol. Drug Interact. 21(3-4), 213-231.

24. Matthews, E. J., Kruhlak, N. L., Weaver, J. L., Benz, R. D., and Contrera, J. F. (2004). Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Curr. Drug Discov. Technol. 1(4), 243-254.

49

25. Ng, C., Xiao, Y., Putnam, W., Lum, B., and Tropsha, A. (2004). Quantitative structure-pharmacokinetic parameters relationships (QSPKR) analysis of

antimicrobial agents in humans using simulated annealing k-nearest-neighbor and partial least-square analysis methods. J. Pharm. Sci. 93(10), 2535-2544.

26. Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., Dorato, M., Van Deun, K., Smith, P., Berger, B., and Heller, A. (2000). Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul. Toxicol. Pharmacol. 32(1), 56-67.

27. Ozer, J., Ratner, M., Shaw, M., Bailey, W., and Schomaker, S. (2008). The current state of serum biomarkers of hepatotoxicity. Toxicology 245(3), 194-205.

28. Roche, O., Trube, G., Zuegge, J., Pflimlin, P., Alanine, A., and Schneider, G. (2002). A virtual screening method for prediction of the HERG potassium channel liability of compound libraries. Chembiochem. 3(5), 455-459.

29. Sakurai, A., Kurata, A., Onishi, Y., Hirano, H., and Ishikawa, T. (2007). Prediction of drug-induced intrahepatic cholestasis: in vitro screening and QSAR analysis of drugs inhibiting the human bile salt export pump. Expert Opin. Drug Saf 6(1), 71- 86.

30. Shen, M., Xiao, Y., Golbraikh, A., Gombar, V. K., and Tropsha, A. (2003b). Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates. J. Med. Chem. 46(14), 3013-3020.

31. Shen, M., Xiao, Y., Golbraikh, A., Gombar, V. K., and Tropsha, A. (2003a). Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates. J. Med. Chem. 46(14), 3013-3020.

32. Tang, W. (2007). Drug metabolite profiling and elucidation of drug-induced hepatotoxicity. Expert Opin. Drug Metab Toxicol 3(3), 407-420.

33. Tostmann, A., Boeree, M. J., Aarnoutse, R. E., de Lange, W. C., van der Ven, A. J., and Dekhuijzen, R. (2008). Antituberculosis drug-induced hepatotoxicity: concise up-to-date review. J Gastroenterol. Hepatol. 23(2), 192-202.

34. Tropsha, A., Gramatica P, and Gombar V.K. (2003). The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models. Quant Struct Act Relat Comb Sci 22, 69-77. 35. Watkins, P. B., Bloom, J., and Hunt, C. Biomarkers of acute idiosyncratic

hepatocellular injury (AIHI) within clinical trials. Institute of Medicine. 2008. Washington, DC.

36. Xu, J. J., Henstock, P. V., Dunn, M. C., Smith, A. R., Chabot, J. R., and de Graaf, D. (2008). Cellular imaging predictions of clinical drug-induced liver injury.

50

37. Zhang, S., Golbraikh, A., Oloff, S., Kohn, H., and Tropsha, A. (2006). A novel automated lazy learning QSAR (ALL-QSAR) approach: method development, applications, and virtual screening of chemical databases using validated ALL- QSAR models. J Chem Inf. Model. 46(5), 1984-1995.

38. Zheng, W., and Tropsha, A. (2000a). Novel variable selection quantitative

structure--property relationship approach based on the k-nearest-neighbor principle.

J. Chem. Inf. Comput. Sci. 40(1), 185-194.

39. Zheng, W., and Tropsha, A. (2000b). Novel variable selection quantitative

structure--property relationship approach based on the k-nearest-neighbor principle.

J Chem. Inf. Comput. Sci 40(1), 185-194.

40. Zhou, S., Chan, E., Duan, W., Huang, M., and Chen, Y. Z. (2005). Drug bioactivation, covalent binding to target proteins and toxicity relevance. Drug

Metab Rev. 37(1), 41-213.

41. Zhu, H., Rusyn, I., Richard, A., and Tropsha, A. (2008). Use of cell viability assay data improves the prediction accuracy of conventional quantitative structure- activity relationship models of animal carcinogenicity. Environ. Health Perspect. 116(4), 506-513.

42. Zimmerman, H. (1998). Drug Induced Hepatic Disease. In Toxicology of the Liver (G.Plaa and W.R.Hewitt, Eds.), 2 ed., pp. 3-60. Taylor & Francis, Washington D.C.